2005
DOI: 10.1016/j.desal.2004.11.031
|View full text |Cite
|
Sign up to set email alerts
|

Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
38
1
3

Year Published

2011
2011
2021
2021

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 122 publications
(46 citation statements)
references
References 9 publications
3
38
1
3
Order By: Relevance
“…In fact, significant variations in the removal of hydrophilic and biologically persistent compounds in the same study and between different studies have been reported in the literature for both MBR and CAS (Clara et al, 2005;Nakada et al, 2006;Tadkaew et al, 2011). Our results regarding the persistence of the above-mentioned six compounds are consistent with the results obtained from our own preliminary study (Nguyen et al, 2012) and other available studies (Clara et al, 2005;Joss et al, 2005;Urase et al, 2005;Nakada et al, 2006;Kimura et al, 2007;Cirja et al, 2008). Similarly, the presence of the strong electron-donating functional groups (such as hydroxyl and aliphatic) and/or absence of strong electron-withdrawing groups appear to be the reason of the high removal of the other hydrophilic compounds such as acetaminophen and salicylic acid , ibuprofen (Clara et al, 2005;Joss et al, 2005) and estriol (Urase et al, 2005;Hai et al, 2011) (Clara et al, 2005;Joss et al, 2005;Urase et al, 2005;Hai et al, 2011).…”
Section: Removal By Mbr Treatmentsupporting
confidence: 92%
“…In fact, significant variations in the removal of hydrophilic and biologically persistent compounds in the same study and between different studies have been reported in the literature for both MBR and CAS (Clara et al, 2005;Nakada et al, 2006;Tadkaew et al, 2011). Our results regarding the persistence of the above-mentioned six compounds are consistent with the results obtained from our own preliminary study (Nguyen et al, 2012) and other available studies (Clara et al, 2005;Joss et al, 2005;Urase et al, 2005;Nakada et al, 2006;Kimura et al, 2007;Cirja et al, 2008). Similarly, the presence of the strong electron-donating functional groups (such as hydroxyl and aliphatic) and/or absence of strong electron-withdrawing groups appear to be the reason of the high removal of the other hydrophilic compounds such as acetaminophen and salicylic acid , ibuprofen (Clara et al, 2005;Joss et al, 2005) and estriol (Urase et al, 2005;Hai et al, 2011) (Clara et al, 2005;Joss et al, 2005;Urase et al, 2005;Hai et al, 2011).…”
Section: Removal By Mbr Treatmentsupporting
confidence: 92%
“…However at higher concentrations, which may be expected in the wastewater of pharmaceutical manufacturing facilities, they may become inhibitory. While there are a number of limited studies on the removal efficiency of APIs from pharmaceutical manufacturing facilities, it is known that removal efficiency of municipal facilities is dependent on the APIs present in the wastewater (Urase et al, 2005). AS is an efficient method for the removal of some APIs, but not all from municipal facilities (Zwiener and Frimmel, 2003;Castiglioni et al, 2006;Watkinson et al, 2007).…”
Section: Conventional Treatment Methodsmentioning
confidence: 99%
“…In the case of the acidic reactor, it is suggested that the removal from the water phase by adsorption took place and the gradual degradation of adsorbed substances on the microbial surface followed. Enhanced removal caused by the promoted adsorption and degradation by low pH operation in MBR was reported for the removal of pharmaceuticals (Urase et al, 2005). It is suggested that the enhanced removal of color by the acidic operation could be explained by the same adsorption -degradation model, though molecular weights of pharmaceuticals would be far smaller than those of colored substances.…”
Section: Possible Mechanism For the Removal Of Colormentioning
confidence: 99%